Downbeat year for Slovenian stocks
The SBI TOP benchmark index on the Ljubljana Stock Exchange lost nearly 16% in 2022, after having risen by almost 40% the year before, show figures released by the stock exchange operator Ljubljanska Borza.
All the big-cap stocks were down with drug maker Krka losing nearly a fifth of its value in a year, NLB bank down by 18%, and energy group Petrol losing 21%.
- Read more about Downbeat year for Slovenian stocks
- Log in to post comments
Pharma group Krka posts record January-June sales, profit
Novo Mesto/Otočec – Pharmaceutical group Krka posted a net profit of EUR 177.4 million for the first half of the year, up 11% on the back of sales that reached EUR 808.6 million, up 1% over the same period last year, CEO Jože Colarič said at the company’s annual general meeting in Otočec on Thursday.
Krka ups sales 3%, net profit 17% to EUR 286.6m last year
Novo Mesto – The Novo Mesto-based pharmaceutical group Krka generated EUR 1.53 billion in revenue last year, up 3% compared to 2019, while net profit has been estimated at EUR 286.6 million, up 17% year-on-year, show the unaudited preliminary results released on Thursday.
Ljubljana and Zagreb stock exchanges happy with investor day
Gažić noted that the considerable interest from investors despite worrying trends on the capital markets made the event satisfying.